NECLIFE.NS

Nectar Lifesciences Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$11.59

Jun 12, 2026

AI Brief

Market cap

$2.25B

52w range

—

P / E

—

EPS · FY 2026

$-14.57

Volume

—

Revenue · FY 2026

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Nectar Lifesciences Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$11.59

Change

-13.12%

Period high

$14.36

Period low

$9.30

Period start

$13.342026-02-01

Through 2026-06-12

Fair value

Football field →

Weighted blend

—

— vs spot

Recommendation

n/a

0 of 0 methods

Method spread

0bull0bear

±5% threshold

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for NECLIFE.NS.

Peers

No peer list available for NECLIFE.NS.

Total assets

$6.22B

Total debt

Cash & equiv

$1.12B

Operating CF

-$3.49B

Free cash flow

-$3.61B

Buybacks

-$810M

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$0	-$590.34M	-$2.93B	$-14.57	—